Simon XiCEO at Rgenta TherapeuticsSpeaker
Agenda Sessions
Unlocking The Therapeutic Potentials Of An Oncogenic Transcription Factor By RNA-Targeting Small Molecules – A Case Study
, 11:40amView Session
This site is part of the Informa Connect Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Unlocking The Therapeutic Potentials Of An Oncogenic Transcription Factor By RNA-Targeting Small Molecules – A Case Study